RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study ; volume:23 ; number:1 ; day:26 ; month:3 ; year:2024 ; pages:1-11 ; date:12.2024
Molecular cancer ; 23, Heft 1 (26.3.2024), 1-11, 12.2024
- Urheber
-
Nelson, Blessie Elizabeth
Roszik, Jason
Ahmed, Jibran
Barretto, Carmelia Maria Noia
Nardo, Mirella
Campbell, Erick
Johnson, Amber M.
Piha-Paul, Sarina A.
Oliva, Isabella C. Glitza
Weathers, Shiao-Pei
Cabanillas, Maria
Javle, Milind
Meric-Bernstam, Funda
Subbiah, Vivek
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-024-01982-4
- URN
-
urn:nbn:de:101:1-2406121204275.958951803767
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nelson, Blessie Elizabeth
- Roszik, Jason
- Ahmed, Jibran
- Barretto, Carmelia Maria Noia
- Nardo, Mirella
- Campbell, Erick
- Johnson, Amber M.
- Piha-Paul, Sarina A.
- Oliva, Isabella C. Glitza
- Weathers, Shiao-Pei
- Cabanillas, Maria
- Javle, Milind
- Meric-Bernstam, Funda
- Subbiah, Vivek
- SpringerLink (Online service)
Ähnliche Objekte (12)
Phospho-proteomic analysis of B-Raf complexes
Mutationsscreening von A-Raf und B-Raf in humanen Glioblastom-Tumorproben
B-Raf specific antibody responses in melanoma patients
Characterization of aberrant pathways across human cancers
B-Raf and the inhibitors: from bench to bedside
Aberrant Expression of Syndecan-1 in Cervical Cancers
RE | -RE- RE | RE | RE | RACE
Functional analysis of the B-raf and raf-1 proto oncogenes in B lymphocytes
Re RE
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : : a retrospective multicenter study
Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf
B-Raf regulation by the dimer interface and activation loop phosphorylation
Phospho-proteomic analysis of B-Raf complexes
Mutationsscreening von A-Raf und B-Raf in humanen Glioblastom-Tumorproben
B-Raf specific antibody responses in melanoma patients
Characterization of aberrant pathways across human cancers
B-Raf and the inhibitors: from bench to bedside
Aberrant Expression of Syndecan-1 in Cervical Cancers
RE | -RE- RE | RE | RE | RACE
Functional analysis of the B-raf and raf-1 proto oncogenes in B lymphocytes
Re RE
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : : a retrospective multicenter study
Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf
B-Raf regulation by the dimer interface and activation loop phosphorylation
Phospho-proteomic analysis of B-Raf complexes
Mutationsscreening von A-Raf und B-Raf in humanen Glioblastom-Tumorproben
B-Raf specific antibody responses in melanoma patients
Characterization of aberrant pathways across human cancers
B-Raf and the inhibitors: from bench to bedside
Aberrant Expression of Syndecan-1 in Cervical Cancers
RE | -RE- RE | RE | RE | RACE
Functional analysis of the B-raf and raf-1 proto oncogenes in B lymphocytes
Re RE
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : : a retrospective multicenter study
Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf